ASCO Daily News

エピソード

• 
  Are We Curing Advanced Melanoma? A Conversation With Dr. Jedd Wolchok 10.09.2026 20分

  Dr. Jedd Wolchok, a pioneer in melanoma research, joins Dr. Monty Pal to break down practice-changing advances in the field, including landmark 10-year CheckMate-067 survival data, safer immunotherapy dosing, and the rise of neoadjuvant treatment. LINK TO FULL TRANSCRIPT  
• 
  Updates in Bladder Cancer: From Intravesical Breakthroughs to Managing Toxicities 03.09.2026 23分

  Dr. Monty Pal and Dr. Petros Grivas discuss the rapidly evolving management of bladder cancer, including key updates in non-muscle-invasive disease, the integration of novel therapies in the advanced setting, and practical strategies for managing toxicities in clinical practice. LINK TO FULL TRANSCRIPT
• 
  How Do We Translate ASCO26 Research Into Practice in Latin America? 20.08.2026 21分

  In part two of our miniseries on the global translation gap in oncology, host Dr. Monty Pal and Dr. Regina Barragán-Carrillo explore how ASCO26 Plenary breakthroughs can be adapted to clinical practice in Latin America. Together, they address real-world implementation challenges including delayed diagnoses, finite resource allocation, and access to precision diagnostics. LINK TO FULL TRANSCRIPT
• 
  GLP-1 Receptor Agonists in GI Cancers: Hype or Promise? 06.08.2026 18分

  Dr. Monty Pal and Dr. Rachna Shroff explore how GLP-1 receptor agonists impact progression and survival in GI cancers, examining current retrospective data, immune microenvironment biology, and the need for prospective trials. LINK TO FULL TRANSCRIPT
• 
  From Abstract to Action: Translating ASCO26 Research Into Global Practice 23.07.2026 24分

  How do we translate oncology breakthroughs into practice? In part one of a two-part miniseries, host Dr. Monty Pal and Dr. Atul Batra discuss the clinical realities, opportunities, and challenges of adapting ASCO26 Plenary findings into cancer care worldwide, using India's health care landscape as a blueprint for resource-limited settings. LINK TO FULL TRANSCRIPT  
• 
  Liquid Biopsy, AI, and Other Global Innovations From 2026 ASCO Breakthrough 09.07.2026 22分

  Dr. Monty Pal and Dr. Roselle De Guzman discuss key abstracts from the 2026 ASCO Breakthrough Meeting, including the real-world impact of liquid biopsies for early multi-cancer detection, AI applications in colorectal cancer screening, and how global advances in breast, esophageal, and small cell lung cancers translate directly to diverse patient populations in the Asia-Pacific region. LINK TO FULL TRANSCRIPT
• 
  Breast Cancer Highlights From ASCO26: OPTIMA, lidERA, and VIKTORIA-1 30.06.2026 24分

  Dr. Megan Kruse and Dr. Hope Rugo discuss practice-changing data in metastatic breast cancer and critical shifts in the treatment of early-stage disease that were presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT
• 
  GU Cancer Highlights From ASCO26: PROTEUS, TALAPRO-3, and RAMPART 25.06.2026 30分

  Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss high-impact abstracts in the treatment of prostate, bladder, and kidney cancers that were presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT
• 
  Immunotherapy Highlights From ASCO26: Cellular Therapy, Melanoma, and Skin Cancers 24.06.2026 29分

  Dr. Pauline Funchain and Dr. Allison Betof discuss practice-changing and paradigm-shifting abstracts in melanoma, Merkel cell carcinoma, and cellular therapies that were presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT
• 
  GI Cancer Highlights From ASCO26: RASolute-302, BREAKWATER, and More 23.06.2026 22分

  Dr. Nilo Azad and Dr. Aparna Parikh discuss high-impact studies in gastrointestinal cancers and other novel treatment approaches that were presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT
• 
  Hematologic Cancer Highlights From ASCO26: MajesTEC-9, frontMIND, and More 19.06.2026 25分

  Dr. Marc Braunstein and Dr. Adam Kittai highlight top research on hematologic malignancies from the 2026 ASCO Annual Meeting, including studies on lymphoid malignancies, multiple myeloma, and plasma cell disorders. LINK TO FULL TRANSCRIPT  
• 
  Lung Cancer Highlights From ASCO26: HARMONi-6, LIBRETTO-436, and More 18.06.2026 22分

  Dr. Christine Lovly and Dr. Vamsi Velcheti discuss practice-changing lung cancer data presented at the 2026 ASCO Annual Meeting, including key studies on squamous cell lung cancer, NSCLC, and SCLC. LINK TO FULL TRANSCRIPT
• 
  Day 5: Top Takeaways From ASCO26 02.06.2026 9分

  Dr. Monty Pal shares highlights from the final day of ASCO26, including new research on treating anemia in myelofibrosis, advances in RAS-mutated mCRC, novel therapies for AML, and a potentially practice-changing trial in TNBC. LINK TO FULL TRANSCRIPT
• 
  Day 4: Top Takeaways From ASCO26 01.06.2026 8分

  Dr. Monty Pal shares highlights from Day 4 of the 2026 ASCO Annual Meeting, including a much-anticipated study in hepatocellular carcinoma, new data in non–small cell lung cancer, and a key update in the treatment of Merkel cell carcinoma. LINK TO TRANSCRIPT
• 
  Day 3: Top Takeaways From ASCO26 31.05.2026 8分

  Dr. Monty Pal shares highlights from Day 3 of the 2026 ASCO Annual Meeting, including new research for the treatment of advanced CRC and mCRPC, TIL cell therapy in advanced non-uveal melanoma, and an ultra-low dose immunotherapy trial in head and neck squamous cell carcinoma. LINK TO FULL TRANSCRIPT
• 
  Day 2: Top Takeaways From ASCO26 30.05.2026 8分

  Dr. Monty Pal shares highlights from Day 2 of the 2026 ASCO Annual Meeting, including a practice-changing trial in renal cell carcinoma, advances in ER-positive, HER2-negative early breast cancer, and the use of olanzapine as an effective steroid-sparing alternative for chemo-induced nausea and vomiting in pediatric cancer. LINK TO FULL TRANSCRIPT
• 
  Day 1: Top Takeaways From ASCO26 29.05.2026 7分

  In the first episode of a special daily series during the 2026 ASCO Annual Meeting, Dr. Monty Pal discusses 3 abstracts, including a follow-up on the EV-302 study in urothelial carcinoma, a potential new treatment option for patients with PD-L1-positive advanced non–small cell lung cancer, and a novel psychosocial digital application that improves fatigue and distress in patients with multiple myeloma. LINK TO FULL TRANSCRIPT
• 
  ASCO26 Preview: Novel Therapies and Innovations in Cancer Care 21.05.2026 23分

  Dr. Monty Pal and Dr. Jo Chien preview new research, hot topics, and emerging innovations in oncology that will be presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT
• 
  The Future of AI in Oncology: A Conversation With Google's AI Innovators 14.05.2026 27分

  Google DeepMind's Dr. Alan Karthikesalingam and Google research scientist Anil Palepu sit down with Dr. Monty Pal to discuss the potential of Articulate Medical Intelligence Explorer (AMIE), a large language model-based experimental medical AI system designed to augment clinical decision-making in oncology and beyond, as well as the future of AI-human collaboration and how it could reshape health care over the next decade. LINK TO FULL TRANSCRIPT
• 
  'No Margin for Error': What to Know Before Implementing AI in Clinical Practice 16.04.2026 18分

  Dr. Monty Pal and Dr. Arturo Loaiza-Bonilla discuss the institutional risks in the use of artificial intelligence (AI) in clinical practice and how overreliance on AI could erode essential skills. They also highlight practical approaches, including routine "AI-off" drills, to help oncologists retain their decision-making agility. LINK TO FULL TRANSCRIPT